Scholars Central

Conference abstractPublished 27 Oct 2016

Novel enzyme therapies for treatment of Cocaine addiction and overdose

Authors: Fang Zheng, Chang-Guo Zhan

University of Kentucky, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

It has been known that cocaine produces the toxic and physiological effects through not only cocaine itself but also norcocaine formed from cocaine oxidation catalyzed by microsomal cytochrome P450 3A4 in the human liver. In addition, majority of cocaine users also consume alcohol, and alcohol can react with cocaine to produce cocaethylene which is significantly more cytotoxic than cocaine. Hence, a truly valuable cocaine-metabolizing enzyme for cocaine abuse/overdose treatment should be efficient for not only cocaine itself, but also its toxic metabolites including norcocaine and cocaethylene. The catalytic parameters (kcat and KM) of human butyrylcholinesterase (BChE) and various mutants (including the one which is under clinical trial for cocaine addiction treatment) for norcocaine and cocaethylene have been characterized in the present study in comparison with those for cocaine. Based on the obtained kinetic data, wild-type human BChE has a lower catalytic activity for norcocaine and cocaethylene compared to its catalytic activity for cocaine. The BChE mutants have considerably improved catalytic activity against norcocaine and cocaethylene compared to the wild-type BChE. One of the BChE mutants, denoted as E12-7, is identified as the most efficient enzyme for hydrolyzing norcocaine and cocaethylene in addition to its high activity for cocaine. E12-7 has a 2020-fold improved catalytic efficiency for cocaine, a 1080-fold improved catalytic efficiency for norcocaine, an 861-fold improved catalytic efficiency for cocaethylene, and a 10-fold improved catalytic efficiency for benzoylecgonine. It has been demonstrated that E12-7 as an exogenous enzyme can indeed rapidly metabolize cocaine, norcocaine and cocaethylene in rats.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Drug Designing: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDrug Designing: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Fang Zheng”
  • BylineArticles whose byline prints “Chang-Guo Zhan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels